India’s Serum Institute expects WHO emergency approval for AstraZeneca shot soon

The Serum Institute of India expects WHO emergency-use authorization soon for the Oxford University/AstraZeneca coronavirus vaccine, which it is producing for mid and low income countries, its chief executive said. “The emergency use licensure from the WHO (World Health Organization) should be available and coming through in the next week or two, hopefully, because we … Read more India’s Serum Institute expects WHO emergency approval for AstraZeneca shot soon

Covid-19 vaccine rollout: How India Inc is gearing up to immunise its employees

As India gets ready to roll out Covid-19 vaccination for health workers from January 16, the next question is: when will a worker on the shop floor or an executive at the front desk of a hotel get their shots? Neither of them will be in the priority group identified by the government. Yet, both … Read more Covid-19 vaccine rollout: How India Inc is gearing up to immunise its employees

Coronavirus News LIVE Updates: Efforts on to Ensure Seamless Last-Mile Delivery of Vaccine, Says Health Minister Harsh Vardhan

Coronavirus News LIVE Updates: World Health Organization experts warned Wednesday there could be six months of “hard, hard road ahead” in 2021 before vaccines turn the tide against the coronavirus pandemic. Source link

Coronavirus Vaccine | Adar Poonawalla : Coronavirus vaccine to cost $3-4 to govt; $6-8 in private market: SII

Coronavirus vaccine developed by AstraZeneca and the University of Oxford will cost USD 3-4 per shot (Rs 219-292) to the government and will be priced at double that rate in private market ones such sales open up, said the CEO of its Indian manufacturer on Monday. Serum Institute of India, the world’s largest vaccine manufacturer, … Read more Coronavirus Vaccine | Adar Poonawalla : Coronavirus vaccine to cost $3-4 to govt; $6-8 in private market: SII

COVID-19: Serum Institute CEO Adar Poonawalla reveals cost of Covishield vaccine – Check price here

The vaccination drive for the vaccine against COVID-19 is expected to begin in India in the coming days. The Drug Controller General of India (DCGI) Dr VG Somani on Sunday (January 3) approved Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin for emergency use against coronavirus. The much-awaited approval by DGCI paved the way … Read more COVID-19: Serum Institute CEO Adar Poonawalla reveals cost of Covishield vaccine – Check price here

India’s Serum Institute says to meet local demand for AstraZeneca vaccine for next two months, before exporting

NEW DELHI : Serum Institute of India (SII), the local maker of the AstraZeneca/Oxford coronavirus vaccine, said on Sunday it intends to concentrate on meeting India’s own immediate demand in the next two months before exporting to other interested countries. Chief Executive Adar Poonawalla said in an interview after the shot was approved for emergency … Read more India’s Serum Institute says to meet local demand for AstraZeneca vaccine for next two months, before exporting

‘Covishield’ ready to roll out in coming weeks: Poonawalla – Times of India

PUNE: Serum Institute of India CEO Adar Poonawalla on Sunday said the Oxford-AstraZeneca Covid-19 vaccine ‘Covishield‘ is ready to roll out in the coming weeks. Poonawalla’s remarks came soon after after India’s drugs regulator approved Covishield for restricted emergency use. “Happy new year, everyone! All the risks @SerumInstIndia took with stockpiling the vaccine, have finally … Read more ‘Covishield’ ready to roll out in coming weeks: Poonawalla – Times of India

Pneumosil: India’s first fully indigenous pneumococcal vaccine launched

New Delhi: Union Health Minister Dr Harsh Vardhan inaugurated India’s first pneumococcal conjugate vaccine, “Pneumosil”, which has been developed by the Serum Institute of India. The vaccine would help in preventing about 67,800 child mortality under 5 years of age in India from pneumococcal diseases every year. The vaccine is developed by the Serum Institute … Read more Pneumosil: India’s first fully indigenous pneumococcal vaccine launched

Government must indemnify vaccine makers against all lawsuits: Adar Poonawalla

NEW DELHI: Vaccine manufacturers need to have protection against all lawsuits for their vaccines especially during a pandemic, Serum Institute of India (SII) Chief Executive Officer Adar Poonawalla has said. He also said that the vaccine makers are going to propose this to the government while speaking at a virtual panel on the challenges of … Read more Government must indemnify vaccine makers against all lawsuits: Adar Poonawalla

Serum Institute Likely to Supply Covid-19 Vaccine at Rs 250 Per Dose to Centre: Report

Serum Institute of India, the world’s largest vaccine producer by volume, is close to signing a supply contract with the country’s Central government and likely to fix prices at 250 rupees ($3.39) per dose of the vaccine, Business Standard reported on Tuesday, citing people familiar with the matter. The government is pinning its hopes for … Read more Serum Institute Likely to Supply Covid-19 Vaccine at Rs 250 Per Dose to Centre: Report